Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
NCT04359667
·
clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Severe Pneumonia
Interventions
DRUG:
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
Sponsor
University Hospital for Infectious Diseases, Croatia